MedPath

Gastrodin prevents cognitive decline related to cardiopulmonary bypass

Not Applicable
Completed
Conditions
eurocognitive decline related to CPB
Nervous System Diseases
Neurocognitive decline
Registration Number
ISRCTN47168298
Lead Sponsor
Tongji Medical College (China)
Brief Summary

2011 results in https://pubmed.ncbi.nlm.nih.gov/21336736/ (added 11/01/2021)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
200
Inclusion Criteria

Adult patients (18 to 65 years) that have undergone mitral valve replacement surgery

Exclusion Criteria

1. Patients who have thrombosis in left atrium
2. A history of symptomatic cerebrovascular disease
3. Diabetes
4. Psychiatric illness
5. Renal disease or active liver disease
6. Less than a seven-grade education or those who cannot read will be excluded

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
eurocognitive function
Secondary Outcome Measures
NameTimeMethod
Safety of gastrodin
© Copyright 2025. All Rights Reserved by MedPath